Dynamic Capital Management Ltd raised its position in Danaher Corporation (NYSE:DHR) by 182.0% during the first quarter, Holdings Channel reports. The fund owned 70,421 shares of the conglomerate’s stock after buying an additional 45,453 shares during the period. Danaher Corporation makes up 1.0% of Dynamic Capital Management Ltd’s holdings, making the stock its 19th largest position. Dynamic Capital Management Ltd’s holdings in Danaher Corporation were worth $6,023,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Peddock Capital Advisors LLC boosted its position in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares during the last quarter. ClariVest Asset Management LLC acquired a new position in shares of Danaher Corporation during the first quarter worth approximately $157,000. Motco boosted its position in shares of Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares during the last quarter. Baystate Wealth Management LLC boosted its position in shares of Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares during the last quarter. Finally, Cedar Wealth Management LLC boosted its position in shares of Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock worth $196,000 after buying an additional 115 shares during the last quarter. 76.56% of the stock is owned by institutional investors and hedge funds.

Shares of Danaher Corporation (NYSE DHR) traded down 0.455% during midday trading on Thursday, reaching $79.865. 166,916 shares of the company were exchanged. The firm has a market capitalization of $55.48 billion, a P/E ratio of 25.492 and a beta of 1.03. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.01. The firm has a 50-day moving average of $83.27 and a 200 day moving average of $84.25.

Danaher Corporation (NYSE:DHR) last announced its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. The company had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. Danaher Corporation’s revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.90 earnings per share. On average, equities research analysts expect that Danaher Corporation will post $3.95 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another publication, it was illegally copied and republished in violation of U.S. & international copyright law. The original version of this report can be read at https://www.dailypolitical.com/2017/08/10/dynamic-capital-management-ltd-acquires-45453-shares-of-danaher-corporation-nysedhr.html.

Several equities research analysts have recently issued reports on DHR shares. Jefferies Group LLC restated a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a report on Friday, August 4th. BidaskClub lowered shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 1st. Wells Fargo & Company started coverage on shares of Danaher Corporation in a report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 target price for the company. Zacks Investment Research lowered shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Finally, BTIG Research restated a “buy” rating and issued a $92.00 target price on shares of Danaher Corporation in a report on Sunday, April 23rd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $91.76.

In other Danaher Corporation news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the transaction, the insider now owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $83.03, for a total transaction of $878,291.34. Following the transaction, the director now directly owns 42,151 shares of the company’s stock, valued at approximately $3,499,797.53. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 38,623 shares of company stock valued at $3,206,426. 12.20% of the stock is currently owned by insiders.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.